Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Benzofuran-Derived Benzylpyridinium Bromides As Potent Acetylcholinesterase Inhibitors Publisher Pubmed



Baharloo F1 ; Moslemin MH1 ; Nadri H2 ; Asadipour A3 ; Mahdavi M4 ; Emami S5 ; Firoozpour L6 ; Mohebat R1 ; Shafiee A4 ; Foroumadi A3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Faculty of Chemistry, Islamic Azad University, Yazd, Iran
  2. 2. Department of Medicinal Chemistry, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  3. 3. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medicinal Sciences, Kerman, Iran
  4. 4. Department of Medicinal Chemistry, Pharmaceutical Sciences Research Center, Tehran University of Medicinal Sciences, Tehran, Iran
  5. 5. Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
  6. 6. Drug Design and Development Research Center, Tehran University of Medicinal Sciences, Tehran, Iran

Source: European Journal of Medicinal Chemistry Published:2015


Abstract

A series of benzofuran-based N-benzylpyridinium derivatives 5a-o were designed and synthesized as novel AChE inhibitors. The synthetic pathway of the compounds involved the preparation of 4-(benzofuran-2-yl)pyridine intermediates via the reaction of different salicylaldehyde derivatives and 4-(bromomethyl)pyridine, followed by intramolecular cyclization. Subsequently, the 4-(benzofuran-2-yl)pyridines were N-benzylated by using appropriate benzyl bromide to afford the final product 5a-o. The results of in vitro AChE activity evaluation of synthesized compounds revealed that all compound had potent anti-AChE activity comparable or more potent than standard drug donepezil. The N-(3,5-dimethylbenzyl) derivative 5e with IC50 value of 4.1 nM was the most active compound, being 7-fold more potent than donepezil. © 2015 Elsevier Masson SAS.